Top news

View all

Nearly 200 million routine vaccine doses allocated to reach millions of children missed during COVID-19 pandemic

The allocation follows a Gavi Board decision in December 2023 to approve US$ 290 million funding for the “Big Catch-Up” initiative.

Gavi and Côte d'Ivoire commit to a successful programmatic and financial transition

Côte d’Ivoire commits to fully finance its routine immunisation programme over the next five years to ensure sustainability beyond Gavi support.

South Sudan Launches R21 Malaria Vaccine Rollout to Protect Children

In a historic move to combat the devastating impact of malaria, the Ministry of Health, in partnership with UNICEF and the World Health Organization and Gavi, The Vaccine Alliance, today launched the nationwide rollout of the R21 malaria vaccine…

VaccinesWork

 

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Visit page

VaccinesWork

 

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Visit page

Top VaccinesWork stories

View all stories

In Zimbabwe, progress on HIV management is also helping protect patients from other deadly threats

Ninety-five percent of Zimbabweans know their HIV status. That means that the more than a million people living with the virus can preventively manage the risk from other dangerous infections, like TB and HPV.

How will Cote d'Ivoire roll out the malaria vaccine?

Yesterday, Côte d'Ivoire made history by becoming the first country to introduce the R21 malaria vaccine into its routine immunisation programme. We spoke to the country's EPI Director to find out how they plan to roll out this lifesaver.

Battling malaria, South Sudan anticipates roll-out of life-saving vaccines

As South Sudan prepares to deploy a new weapon in its fight against malaria, the R21 vaccine, Winnie Cirino surveys the parasitic disease’s foothold. 

Vaccines support

Gavi supports vaccines against 20 infectious diseases, including COVID-19, Ebola, malaria and rabies. Learn more about our support for each vaccine by clicking below.

Visit page

Gavi supports vaccines against 20 infectious diseases, including COVID-19, Ebola, malaria and rabies. Learn more about our support for each vaccine by clicking below.

Visit page

Our impact

Children >1 billion children vaccinated through routine programmes
First aid locator >17.3 million future deaths averted
Transitioned 19 countries fully self-financing
Billions >220.5 US$ billion in economic benefits for countries
Syringe 1.8 billion vaccinations through preventive vaccination campaigns

Our mission: save lives and protect people's health

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Visit page

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Visit page

Our partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Subscribe to our newsletter